147
Participants
Start Date
July 31, 2025
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2027
ESV
This study arm will undergo ESV treatment and also receive optimal medical management, including smoking cessation program support, pulmonary rehabilitation, usual medications and oxygen supplementation as necessary.
EBV
This study arm will undergo EBV treatment and also receive optimal medical management, including smoking cessation program support, pulmonary rehabilitation, usual medications and oxygen supplementation as necessary.
China-Japan Friendship Hospital, Beijing
Beijing Cardiotech Medical Technology CO., LTD
UNKNOWN
China-Japan Friendship Hospital
OTHER